Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

<sup>68</sup>Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy.

Auteurs : Shagera QA, Artigas C, Karfis I, Critchi G, Martinez Chanza N, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P
Jaar : 2021
Journal : J Nucl Med

Oligometastatic Disease Detection with <sup>68</sup>Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.

Auteurs : Artigas C, Diamand R, Shagera QA, Plouznikoff N, Fokoue F, Otte FX, Gil T, Peltier A, Van Gestel D, Flamen P
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.

Auteurs : Martinez Chanza N, Bernard B, Barthelemy P, Accarain A, Paesmans M, Desmyter L, Tkint de Roodenbeke D, Gil T, Sideris S, Roumeguere T, Hamid AA, Sweeney CJ
Jaar : 2021
Journal : Prostate Cancer Prostatic Dis

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis.

Auteurs : Dumont L, Salaroli A, Dal Lago L, Gil T, Pepersack T
Jaar : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pagina's : 002425

An update on the management of metastatic clear-cell renal cell carcinoma: the BSMO Expert panel recommendations

Auteurs : Delafontaine B, De Backer D, Beuselinck B, Debruyne P, DHondt L, Gennigens C, Gil T, Vulsteke C, Martinez Chanza N, Verbiest A, Strijbos M, Van Lancker G, Pelgrims G, Rottey S
Jaar : 2020
Journal : Belgian J Medical Oncology
Volume : 14(2)
Pagina's : 56–70